3,5-Dinitrocatechol

Identification

Generic Name
3,5-Dinitrocatechol
DrugBank Accession Number
DB02105
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 200.1058
Monoisotopic: 200.00693587
Chemical Formula
C6H4N2O6
Synonyms
Not Available
External IDs
  • OR 486
  • OR-486
  • OR486

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UCatechol O-methyltransferaseNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AmisulprideThe therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Amisulpride.
ApomorphineThe metabolism of Apomorphine can be decreased when combined with 3,5-Dinitrocatechol.
AripiprazoleThe therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Aripiprazole.
Aripiprazole lauroxilThe therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Aripiprazole lauroxil.
AsenapineThe therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Asenapine.
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as dinitrophenols. These are organic aromatic compounds containing a benzene that carries a single phenol group and exactly two nitro groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Phenols
Sub Class
Nitrophenols
Direct Parent
Dinitrophenols
Alternative Parents
Nitrobenzenes / Nitroaromatic compounds / Catechols / 1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds
show 2 more
Substituents
1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / Allyl-type 1,3-dipolar organic compound / Aromatic homomonocyclic compound / C-nitro compound / Catechol / Dinitrophenol / Hydrocarbon derivative / Monocyclic benzene moiety / Nitroaromatic compound
show 11 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
VK0VA22GY2
CAS number
7659-29-2
InChI Key
VDCDWNDTNSWDFJ-UHFFFAOYSA-N
InChI
InChI=1S/C6H4N2O6/c9-5-2-3(7(11)12)1-4(6(5)10)8(13)14/h1-2,9-10H
IUPAC Name
3,5-dinitrobenzene-1,2-diol
SMILES
OC1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O

References

General References
Not Available
PubChem Compound
3870203
PubChem Substance
46507481
ChemSpider
3094995
BindingDB
50017846
ChEMBL
CHEMBL168276
ZINC
ZINC000002170217
PDBe Ligand
DNC
PDB Entries
1vid / 3a7e / 3bwm / 3bwy / 5fhq / 5fhr / 5lsa / 6i3c / 6i3d

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.605 mg/mLALOGPS
logP1.71ALOGPS
logP1.25Chemaxon
logS-2.5ALOGPS
pKa (Strongest Acidic)4.89Chemaxon
pKa (Strongest Basic)-6.6Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area126.74 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity42.66 m3·mol-1Chemaxon
Polarizability15.48 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.6447
Blood Brain Barrier-0.8405
Caco-2 permeable-0.5546
P-glycoprotein substrateNon-substrate0.7887
P-glycoprotein inhibitor INon-inhibitor0.804
P-glycoprotein inhibitor IINon-inhibitor0.9727
Renal organic cation transporterNon-inhibitor0.9491
CYP450 2C9 substrateNon-substrate0.769
CYP450 2D6 substrateNon-substrate0.8708
CYP450 3A4 substrateNon-substrate0.5762
CYP450 1A2 substrateNon-inhibitor0.9045
CYP450 2C9 inhibitorInhibitor0.8948
CYP450 2D6 inhibitorNon-inhibitor0.923
CYP450 2C19 inhibitorNon-inhibitor0.9154
CYP450 3A4 inhibitorNon-inhibitor0.8585
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8682
Ames testNon AMES toxic0.5959
CarcinogenicityNon-carcinogens0.6665
BiodegradationNot ready biodegradable0.8925
Rat acute toxicity2.7748 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8597
hERG inhibition (predictor II)Non-inhibitor0.9107
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0udi-3920000000-b9c8a21d3136f40e4755
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-145.6882543
predicted
DarkChem Lite v0.1.0
[M-H]-145.3906543
predicted
DarkChem Lite v0.1.0
[M-H]-123.72534
predicted
DeepCCS 1.0 (2019)
[M+H]+146.2731543
predicted
DarkChem Lite v0.1.0
[M+H]+146.6484543
predicted
DarkChem Lite v0.1.0
[M+H]+126.98663
predicted
DeepCCS 1.0 (2019)
[M+Na]+145.7704543
predicted
DarkChem Lite v0.1.0
[M+Na]+145.6860543
predicted
DarkChem Lite v0.1.0
[M+Na]+135.2054
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
O-methyltransferase activity
Specific Function
Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOP...
Gene Name
COMT
Uniprot ID
P21964
Uniprot Name
Catechol O-methyltransferase
Molecular Weight
30036.77 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52